China has approved CSPC Pharma’s RSV vaccine for clinical trials

China’s National Drug Administration has issued a release authorization to pharmaceutical group CSPC The drugmaker said it will begin clinical trials of a respiratory syncytial virus (RSV) vaccine in humans.

Compartir esta publicacion:

ENTRADAS POPULARES
SÍGANOS
Danos like en facebook
Síganos en Twitter
Suscríbase a nuestro canal
Tik Tok
TRANSMISIÓN EN VIVO